Detalles de la búsqueda
1.
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.
Cancer Immunol Immunother
; 65(2): 205-11, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26759007
2.
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
Cancer Immunol Immunother
; 62(6): 983-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23591978
3.
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.
Blood
; 118(11): 3003-12, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21768296
4.
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
Clin Cancer Res
; 14(18): 5759-68, 2008 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18794085
5.
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.
J Immunol Methods
; 339(1): 74-81, 2008 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-18775433
6.
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
Clin Cancer Res
; 24(15): 3611-3631, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703821
7.
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Cancer Res
; 78(1): 256-264, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29093005
8.
Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity.
J Neuroimmunol
; 182(1-2): 63-72, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17137636
9.
Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers.
Clin Cancer Res
; 12(24): 7306-15, 2006 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17189402
10.
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Clin Cancer Res
; 23(8): 1898-1909, 2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28411277
11.
The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Clin Neurosurg
; 56: 98-106, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20214040
12.
EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.
Clin Cancer Res
; 20(4): 972-84, 2014 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24352643
13.
Myeloablative temozolomide enhances CD8⺠T-cell responses to vaccine and is required for efficacy against brain tumors in mice.
PLoS One
; 8(3): e59082, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23527092
14.
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
PLoS One
; 7(2): e31046, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22383993
15.
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
J Clin Oncol
; 28(31): 4722-9, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20921459
Resultados
1 -
15
de 15
1
Próxima >
>>